Download PDF
Semin intervent Radiol 2019; 36(05): 367-373
DOI: 10.1055/s-0039-1696650
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Thermal Ablation of T1a Renal Cell Carcinoma: The Clinical Evidence

Shamar Young
1   Department of Radiology, University of Minnesota, Minneapolis, Minnesota
,
Jafar Golzarian
2   Department of Radiology and Surgery, University of Minnesota, Minneapolis, Minnesota
,
J. Kyle Anderson
3   Department of Urology, University of Minnesota, Minneapolis, Minnesota
› Author Affiliations
Further Information

Publication History

Publication Date:
02 December 2019 (online)

Also available at
   Buy Article Permissions and Reprints
Zoom Image

Abstract

Renal cell carcinoma (RCC) is most commonly diagnosed at an early (T1a) stage and is typically amenable to several effective treatments. The current gold standard therapy is partial nephrectomy, given its decreased morbidity and similar oncologic outcomes when compared with radical nephrectomy. Thermal ablation is an evolving definitive therapy for T1a RCC which is even less invasive than partial nephrectomy. This article reviews the evidence for thermal ablation in the treatment of T1a RCC and compares outcomes of existing ablation modalities with surgical management.

Keywords

renal cell carcinoma - partial nephrectomy - cryoablation - thermal ablation - microwave ablation - radiofrequency ablation